Clinical trial Recruiting at 1 site Observational

Registry for new cases of multiple sclerosis in Lorraine

Official title: Lorraine Registry of Multiple Sclerosis

Run by Central Hospital, Nancy, France · NCT02883335 · Data updated 2026-11-12

This study is creating a detailed record of all new multiple sclerosis cases in the Lorraine region of France to better understand the condition and its impact on patients.

Quick facts

Study typeObservational
SexAll
Enrollment6000 (estimated)
SponsorCentral Hospital, Nancy, France
Academic / other
Locations1 site (Nancy)
StatusRecruiting
StartedMay 2003
Main results expectedJanuary 2030
Study endsJanuary 2030
Registry record updatedFebruary 8, 2023
Trial IDNCT02883335 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this registry are individuals with a confirmed diagnosis of multiple sclerosis who reside in the Lorraine region.

Probably not a fit

Patients who do not have a confirmed diagnosis of multiple sclerosis or who refuse to be registered will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Lorraine Registry of Multiple Sclerosis aims to comprehensively document every new case of multiple sclerosis (MS) occurring in the Lorraine region of France and to follow these cases indefinitely. The registry collects data from various sources, including neurologists, patient networks, and health insurance data, ensuring thoroughness and accuracy. Each identified case is confirmed by neurologists, and the registry employs both automated and manual checks to maintain data integrity. Regular audits and reports on the incidence and prevalence of MS in Lorraine are conducted to evaluate the quality of the data collected.

Why it matters

Potential benefit: If successful, this registry could provide valuable insights into the epidemiology and progression of multiple sclerosis, potentially leading to improved patient care and treatment strategies.

How similar studies have gone: Other patient registries for multiple sclerosis have shown success in improving understanding and management of the disease, indicating that this approach is both valuable and tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Having a confirmed multiple sclerosis diagnosis
* Living in Lorraine (French region)

Exclusion Criteria:

* Refusal to be registered

Where it's running

  • CIC 1433 Épidémiologie clinique, Inserm, Université de Lorraine, CHRU de Nancy
    Nancy, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.